Stripe co-founder says high interest rates wiped out ‘wackiest’ ideas

John Collison, president and co-founder of Stripe. Christophe Morin | IP3 | Getty Images Rising interest rates crushed technology valuations and had a chilling effect on Silicon Valley. Stripe’s co-founder says it was needed. “Broadly speaking, the effects of higher rates have been quite good,” John Collison, president of the online payments company, told CNBC … Read more

(RBRK) starts trading on New York Stock Exchange

Bipul Sinha, CEO, Chairman & Co-Founder of Rubrik Inc., the Microsoft backed cybersecurity software startup, rings the opening bell during his company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., April 25, 2024.  Brendan Mcdermid | Reuters Data management software maker Rubrik jumped in its New York Stock Exchange debut on Thursday, … Read more

Activist Ancora wins Teamster union support

Activist Ancora on Thursday won the support of the BMWED Teamsters in the investor’s efforts to oust Norfolk Southern CEO Alan Shaw and a majority of the railroad’s 13-person board. The labor group said it would back the activist’s seven director nominees over Norfolk Southern management, a significant endorsement in an industry unusually dependent on … Read more

Economy increased at a 1.6% rate

U.S. economic growth was much weaker than expected to start the year, and prices rose at a faster pace, the Commerce Department reported Thursday. Gross domestic product, a broad measure of goods and services produced in the January-through-March period, increased at a 1.6% annualized pace when adjusted for seasonality and inflation, according to the department’s … Read more

Bristol Myers Squibb (BMY) earnings Q1 2024

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023.  Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and several new drugs posted sales growth. But the pharmaceutical company … Read more

Merck (MRK) earnings Q1 2024

Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its … Read more

Walgreens launches cell, gene therapies in service expansion

A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty … Read more

Biogen (BIIB) earnings Q1 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched Alzheimer’s drug, Leqembi, came in higher than expected. Biogen and … Read more

3.6 million Medicare patients could get heart health coverage

More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug is also approved in the U.S. for heart health, according to an analysis released Wednesday by health policy research organization KFF. But some eligible beneficiaries could still face out-of-pocket costs for the highly popular … Read more

Labor Department cracks down on bad retirement savings advice

The U.S. Department of Labor headquarters in Washington. Al Drago/Bloomberg via Getty Images The Biden administration issued a final rule on Tuesday that cracks down on the investment advice that advisors, brokers, insurance agents and others give to retirement savers. The U.S. Department of Labor regulation — which follows a rule proposal in October — … Read more